Join
Live feed
·
PRReleasevia Quantisnow
Codiak BioSciences Inc. logo

Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING™ and exoIL-12™

ByQuantisnow·Wall Street's wire, on your screen.
CDAK· Codiak BioSciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDAK (Codiak BioSciences Inc.) and more on Quantisnow.